La cadena de opciones muestra datos clave de las opciones de acciones de Clorox a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Clorox..

Clorox (NYSE:CLX) Bolsa, Cadena de Opciones

Clorox

Since its inception more than 100 years ago, Clorox has grown to play in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just less than 85% of Clorox's sales stem from its home turf.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

NXPI

TBNK

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: TSN, CLX, TBNK, FN y NXPI.

5 acciones en el foco este lunes: TSN, CLX, TBNK, FN y NXPI

After-Hours Center

Movers

Clorox reporta ganancias trimestrales que superan las expectativas. Las acciones suben un 4,37% tras la publicación de los resultados.

Acciones de Clorox suben tras resultados del segundo trimestre

Clorox Co

Calix Ltd

COLLEXIS HOLDINGS INC by Collexis Holdings, Inc.

U.S. stock futures dropped sharply on Monday after U.S. President Donald Trump imposed tariffs on three of its major trade partners, Canada, China, and Mexico.
The new tariffs will begin Tuesday, with a 10% levy on China and a 25% levy on a few Canadian and Mexican imports, each. The U.S. Chamber of Commerce warns of supply chain disruptions and higher family costs, citing concerns over trade with Mexico worth $46 billion in agricultural products, and Canada valued at $97 billion in energy supplied.
The U.S. dollar index strengthened over 1% following this announcement.
All major index futures were down, with the Russell 2000 falling more than 2%. This drop comes after the indices had posted gains for three consecutive weeks.
Companies reporting earnings this week include Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Google parent Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), and Fortinet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>).
The 10-year Treasury yield stood at 4.54%, while the two-year yield was at 4.27%. According to the CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>, there is an 86.5% chance that the Federal Reserve will keep interest rates unchanged for the March meeting.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-1.78%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.57%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-1.38%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-2.14%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) both experienced negative premarket trading on Monday. SPY fell 1.51% to $592.76, and QQQ plunged 1.72% to $513.33, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Energy, IT, and materials stocks led the decline on Friday as the U.S. markets reacted to new tariffs on the country's three largest suppliers &#8211; Canada, Mexico, and China.
Communication services and consumer discretionary stocks were exceptions. The news overshadowed strong earnings from Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>).
On the economic front, the U.S. personal income rose 0.4% in December (up from 0.3% in November), while personal spending climbed 0.7% to an annualized rate of $20.387 trillion. The core PCE price index increased 0.2%.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.28%</td>
<td>19,627.44</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.50%</td>
<td>6,040.53</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.75%</td>
<td>44,544.66</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.86%</td>
<td>2,287.69</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
The newly issued tariffs as highlighted by Treasury Secretary Scott Bessent will be used to bring manufacturing back to the U.S. It will also be used to raise revenues to help pay for extending Trump&#8217;s 2017 tax cuts and as a lever to negotiate with other countries as an alternative to sanctions.
However, Ed Yardeni and Eric Wallerstein in their QuickTakes note mentioned that &#8220;During Trump 1.0, tariff hikes by the U.S. seem to have depressed merchandise imports in 2018 and 2019. But they also depressed U.S. exports because global economic growth was weakened by trade tensions.&#8221;
Ryan Detrick, the chief market strategist at Carson Research highlighted in an X post that February is historically the worst month during a post-election year.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">February is historically the worst year during a post election year, so maybe rough seas this month shouldn&#39;t be a shock? Is it just a President likes to get all the bad stuff out of the way early? <a href="https://t.co/kooyDUoqs7">pic.twitter.com/kooyDUoqs7</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1886221160209363356?ref_src=twsrc%5Etfw">February 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Furthermore, Detrick pointed out that &#8220;the first quarter of a post-election year usually isn&#8217;t all that strong.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Yes, it was a very strong January for stocks, but be aware the first quarter of a post-election year usually isn&#39;t all that strong. <a href="https://t.co/nZx4SPu4XX">pic.twitter.com/nZx4SPu4XX</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1886223993058812398?ref_src=twsrc%5Etfw">February 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He added that the S&amp;P 500 has been up eight of the past nine quarters. &#8220;One of these days it&#8217;ll fall and that is perfectly normal.&#8221;
According to Ivan Martchev, investment strategist at Navellier &amp; Associates, &#8220;Seasonality is not a promise.&#8221;
Martchev highlighted that December was supposed to be strong, but it turned out to be weak. He added that since 1928, September has been the weakest seasonal month, but last year only the first week was down while the rest of the month was strong.
&#8220;So as we approach February which is weak over the long term, we must remember that seasonality is a guideline, but it can deviate widely each year,&#8221; he added.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a> 
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on for the week:
<ul>
<li>On Monday, January&#8217;s S&amp;P final U.S. manufacturing PMI will be released at 9:45 a.m., ET.</li>
</ul>
<ul>
<li>December&#8217;s construction spending data and January&#8217;s ISM manufacturing data will be announced at 10:00 a.m., ET.</li>
</ul>
<ul>
<li>Atlanta Fed President Raphael Bostic will speak at noon, and auto sales data for January will also be released on Monday.</li>
</ul>
<ul>
<li>On Tuesday, December&#8217;s job openings and factory orders data will be out at 10:00 a.m., ET</li>
</ul>
<ul>
<li>Atlanta Fed President Raphael Bostic will speak again at 11:00 a.m., ET on Tuesday, on the topic of housing.</li>
</ul>
<ul>
<li>San Francisco Fed President Daly will speak at 2:00 p.m., ET and Federal Reserve Vice Chairman Philip Jefferson will speak at 7:30 p.m., ET.</li>
</ul>
<ul>
<li>On Wednesday, January&#8217;s ADP employment data will be out at 8:15 a.m., and December&#8217;s U.S. trade deficit data will be released at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Richmond Fed President Tom Barkin will speak at 9:00 a.m., ET.</li>
</ul>
<ul>
<li>January&#8217;s S&amp;P final U.S. services PMI will be announced at 9:45 a.m. and ISM services data will be out by 10:00 a.m., ET.</li>
</ul>
<ul>
<li>Chicago Fed President Goolsbee will speak at 1:00 p.m., Fed Governor Michelle Bowman will speak at 3:00 p.m., and Fed Vice Chairman Philip Jefferson will speak again at 7:30 p.m., ET.</li>
</ul>
<ul>
<li>On Thursday, initial jobless claims till Feb. 1 and the U.S. productivity data for the fourth quarter will be out at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Fed Governor Christopher Waller will speak at 2:30 p.m. and Dallas Fed President Lorie Logan will speak at 5:10 p.m., ET.</li>
</ul>
<ul>
<li>On Friday, the U.S. employment, unemployment, and hourly wages report for January will be out at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Fed Governor Michelle Bowman will speak again at 9:25 a.m., ET.</li>
</ul>
<ul>
<li>December&#8217;s wholesale inventory data will be announced at 10:00 a.m., ET.</li>
</ul>
<ul>
<li>January&#8217;s preliminary consumer sentiment data will be out at 10:00 a.m., ET.</li>
</ul>
<ul>
<li>December&#8217;s consumer credit will be released at 3:00 p.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) was down 2.68% in the premarket on Monday as it is expected to report its fourth-quarter earnings after market hours. According to Benzinga's consensus estimates, the company is expected to report earnings of $0.11 per share on revenue of $775.91 million.</li>
</ul>
<ul>
<li>Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) declined 3.26% as it is expected to report its earnings after having missed filing reports since March 31 quarterly results in May 2024.</li>
</ul>
<ul>
<li>MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) slipped 5.73% as Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell over 4% to $95,403.03 per coin.</li>
</ul>
<ul>
<li>Tyson Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) was up 1.56% ahead of its earnings before the opening bell. Analysts expect it to report quarterly earnings of 88 cents per share on revenue of $13.44 billion.</li>
</ul>
<ul>
<li>Clorox Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) was down 0.20% as Wall Street expects it to report quarterly earnings of $1.41 per share on revenue of $1.63 billion after the closing bell.</li>
</ul>
<ul>
<li>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) declined 2.87% ahead of its earnings after the closing bell. Analysts expect it to report quarterly earnings of $2.50 per share on revenue of $814.33 million.</li>
</ul>
<ul>
<li>NXP Semiconductors NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) dropped 2.56% as Wall Street expects it to report quarterly earnings of $3.14 per share on revenue of $3.10 billion after the closing bell.</li>
</ul>
<ul>
<li>Territorial Bancorp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBNK#NASDAQ">TBNK</a>) was down 7.52% after it reported a net loss of $1.72 million, or 20 cents per share, for the fourth quarter.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 2.29% to hover around $74.19 per barrel.
The gold spot index was down by 0.16% to $2,796.63 per ounce. The Dollar Index was up 1.09% at 109.554 level.
Asian markets fell sharply on Monday as Hong Kong's Hang Seng, Australia's ASX 200, South Korea's Kospi, China's CSI 300, and Japan's Nikkei 225 index declined. European markets were also lower in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43428231/as-dollar-strengthens-after-trumps-tariff-imposition-this-hedge-fund-manager-says-usd-devaluation-is-inevitable-heres-why">Trump Tariffs Strengthen Dollar, But Hedge Fund CEO Sees Impending Decline</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Market Summary

Futures

Economics

$BTC

AMZN

FTNT

GOOG

GOOGL

MSTR

PLTR

SMCI

US Stocks Likely To Open Lower As Trump Imposes Tariffs On China, Canada, And Mexico: Expert Notes Feb Worst Month In Post-Election Years

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Tyson Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) to report quarterly earnings at 88 cents per share on revenue of $13.44 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Tyson Foods shares gained 0.2% to $56.60 in after-hours trading.</li>
<li>Analysts are expecting Clorox Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) to post quarterly earnings at $1.41 per share on revenue of $1.63 billion. The company will release earnings after the markets close. Clorox shares slipped 0.2% to $158.36 in after-hours trading.</li>
<li>Territorial Bancorp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBNK#NASDAQ">TBNK</a>) reported a net loss of $1.72 million, or 20 cents per share, for the fourth quarter. Territorial Bancorp shares fell 0.9% to $9.03 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>After the closing bell, Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) is projected to post quarterly earnings at $2.50 per share on revenue of $814.33 million. Fabrinet shares slipped 0.1% to $216.13 in after-hours trading.</li>
<li>Analysts expect NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) to post quarterly earnings at $3.14 per share on revenue of $3.10 billion after the closing bell. NXP Semiconductors shares fell 0.1% to $208.43 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43390127/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Tyson Foods, Clorox And 3 Stocks To Watch Heading Into Monday

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &#8220;Neutral&#8221; zone on Friday.
U.S. stocks settled lower on Friday, with the Dow Jones index falling more than 300 points during the session after the White House confirmed that new tariffs on imports from Canada, Mexico, and China would take effect on Saturday, escalating trade tensions with the country&#8217;s three largest suppliers.
Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) reported better-than-expected first-quarter financial results after the market closed on Thursday. Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) reported stronger-than-expected fourth-quarter earnings.
On the economic data front, U.S. personal income increased 0.4% month-over-month in December compared to a 0.3% gain in November. Personal spending climbed by 0.7% month-over-month to an annualized rate of $20.387 trillion in December. The core PCE price index in the US increased by 0.2% from the previous month for December.
Most sectors on the S&amp;P 500 closed on a negative note, with energy, information technology, and materials stocks recording losses on Friday. However, communication services and consumer discretionary stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 337 points to 44,544.66 on Thursday. The S&amp;P 500 fell 0.50% to 6,040.53, while the Nasdaq Composite fell 0.28% at 19,627.44 during Friday's session.
Investors are awaiting earnings results from Tyson Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>), Clorox Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>), and NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 45.8, the index remained in the &#8220;Neutral&#8221; zone on Friday, versus a prior reading of 49.4.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43390127/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Long Ideas

AAPL

Dow Dips Over 300 Points As Trump Imposes Tariffs On Canada, Mexico, And China: Fear & Greed Index Remains In 'Neutral' Zone

<h3>Companies Reporting Before The Bell</h3>
• Tyson Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) is projected to report quarterly earnings at $0.88 per share on revenue of $13.46 billion. 
• Saia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) is projected to report quarterly earnings at $2.77 per share on revenue of $780.35 million. 
• Alliance Res Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARLP#NASDAQ">ARLP</a>) is likely to report quarterly earnings at $0.67 per share on revenue of $635.60 million. 
• Johnson Outdoors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JOUT#NASDAQ">JOUT</a>) is estimated to report quarterly loss at $1.30 per share on revenue of $104.73 million. 
• Lavoro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVRO#NASDAQ">LVRO</a>) is estimated to report quarterly loss at $0.37 per share on revenue of $373.85 million. 
• NAPCO Security Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSSC#NASDAQ">NSSC</a>) is estimated to report quarterly earnings at $0.34 per share on revenue of $49.88 million. 
• Twist Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) is expected to report quarterly loss at $0.63 per share on revenue of $86.95 million. 
• IDEXX Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDXX#NASDAQ">IDXX</a>) is estimated to report quarterly earnings at $2.40 per share on revenue of $936.68 million. 
<h3>Companies Reporting After The Bell</h3>
• BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) is expected to report quarterly earnings at $0.48 per share on revenue of $524.74 million. 
• New Jersey Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NJR#NYSE">NJR</a>) is estimated to report quarterly earnings at $1.06 per share on revenue of $468.00 million. 
• Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) is likely to report quarterly earnings at $1.77 per share on revenue of $997.10 million. 
• KKR Real Estate Finance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KREF#NYSE">KREF</a>) is likely to report quarterly loss at $0.07 per share on revenue of $34.78 million. 
• Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) is estimated to report quarterly earnings at $2.49 per share on revenue of $813.57 million. 
• Kyndryl Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KD#NYSE">KD</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $3.81 billion. 
• Everest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) is estimated to report quarterly loss at $17.08 per share on revenue of $3.93 billion. 
• Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) is likely to report quarterly earnings at $1.00 per share on revenue of $754.93 million. 
• Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) is likely to report quarterly earnings at $1.40 per share on revenue of $1.63 billion. 
• J&amp;J Snack Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JJSF#NASDAQ">JJSF</a>) is estimated to report quarterly earnings at $0.59 per share on revenue of $360.85 million. 
• Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $691.84 million. 
• Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) is expected to report quarterly earnings at $0.11 per share on revenue of $775.91 million. 
• MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) is expected to report quarterly earnings at $0.66 per share on revenue of $303.53 million. 
• AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) is estimated to report quarterly earnings at $1.10 per share on revenue of $4.11 billion. 
• Capital Southwest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSWC#NASDAQ">CSWC</a>) is likely to report quarterly earnings at $0.62 per share on revenue of $50.62 million. 
• Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) is estimated to report quarterly earnings at $1.18 per share on revenue of $772.98 million. 
• Sun Country Airlines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCY#NASDAQ">SNCY</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $258.04 million. 
• Flexsteel Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLXS#NASDAQ">FLXS</a>) is estimated to report quarterly earnings at $0.74 per share on revenue of $104.61 million. 
• RBB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBB#NASDAQ">RBB</a>) is expected to report quarterly earnings at $0.36 per share on revenue of $28.12 million. 
• NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) is likely to report quarterly earnings at $3.13 per share on revenue of $3.10 billion. 
• Kforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NYSE">KFRC</a>) is projected to report quarterly earnings at $0.59 per share on revenue of $341.43 million. 
• Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) is expected to report quarterly earnings at $0.47 per share on revenue of $160.29 million. 
• NewMarket (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEU#NYSE">NEU</a>) is estimated to report earnings for its fourth quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARLP

BRBR

CSWC

FLXS

IDXX

JJSF

JOUT

KFRC

KREF

LVRO

NSSC

RMBS

SAIA

SNCY

TWST

Earnings Scheduled For February 3, 2025

Throughout the last three months, 6 analysts have evaluated Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Clorox, revealing an average target of $158.17, a high estimate of $171.00, and a low estimate of $130.00. Witnessing a positive shift, the current average has risen by 3.26% from the previous average price target of $153.17.
<img src="https://www.benzinga.com/files/images/story/2025/1738267262_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive Clorox is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$150.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$130.00</td>
<td>$139.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$171.00</td>
<td>$167.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$157.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Robert Moskow</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$170.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$171.00</td>
<td>$153.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Clorox. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Clorox compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Clorox's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Clorox's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CLX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Clorox analyst ratings.</a>
<h2>All You Need to Know About Clorox</h2>
Since its inception more than 100 years ago, Clorox has grown to play in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just less than 85% of Clorox's sales stem from its home turf.
<h3>Unraveling the Financial Story of Clorox</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Clorox's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 27.13% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Net Margin: Clorox's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 5.62%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 51.03%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 1.76%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 48.07, Clorox faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

What Analysts Are Saying About Clorox Stock

RBC Capital analyst Nik Modi reiterates Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) with a Sector Perform and maintains $150 price target.

Price Target

Reiteration

RBC Capital Reiterates Sector Perform on Clorox, Maintains $150 Price Target

The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) said that CFO Kevin Jacobsen will retire on April 1 after <a href="https://www.benzinga.com/pressreleases/25/01/n43287483/clorox-cfo-kevin-jacobsen-to-retire-luc-bellet-named-cfo">almost 30 years at the company</a>.
Luc Bellet, who has been with Clorox for 18 years, will take over from Jacobsen as the new CFO.
Jacobsen, who has held the CFO position since 2018, was pivotal in driving the company&#8217;s IGNITE strategy and improving its financial results. 
Jacobsen will continue to assist in an advisory capacity until his complete retirement in June 2025, ensuring a smooth transition with his successor, Luc Bellet.
&#8220;Our business is in a position of operational strength and we&#8217;re embarking on an important phase of growth through our digital transformation,&#8221; said Jacobsen.
Also Read: <a href="https://www.benzinga.com/25/01/43266329/royal-caribbean-cruises-q4-benefits-from-strong-demand-stock-surges">Royal Caribbean Cruises&#8217; Q4 Benefits From Strong Demand</a>
&#8220;Luc is the right leader to drive our business forward at this time, and I&#8217;m confident that his vast experience across all aspects of our business will enable continued growth and success.&#8221;
Bellet is currently serving as the company&#8217;s treasurer, and has held key leadership positions in areas such as financial planning, internal audit, and business development. 
Starting April 1, he will be promoted to executive vice president and CFO, reporting to CEO Linda Rendle and joining the executive committee.
&#8220;We are fortunate to have a strong leader in&nbsp;Luc Bellet&nbsp;ready to step into this important role, which is a testament to Kevin&#8217;s continued development of his team and our thoughtful succession planning,&#8221; said Rendle.
In November, the company appointed Stephen Bratspies and Pierre Breber to its <a href="https://www.benzinga.com/pressreleases/24/11/n42099665/clorox-announces-election-of-stephen-bratspies-and-pierre-breber-to-its-board-of-directors">board of directors</a>.
Price Action: Clorox shares are trading lower by 0.69% at $157.18 at the last check Wednesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43302258/apparel-company-vf-corp-beats-q3-expectations-north-face-climbs-vans-slips">Apparel Company VF Corp Beats Q3 Expectations: North Face Climbs, Vans Slips</a></li>
</ul>
Image: Shutterstock

General

Clorox Appoints New CFO As Kevin Jacobsen Retires After Three Decades

Kevin will actively serve in his CFO role through the transition on April 1 and then continue at Clorox in an advisory capacity until his retirement in June. &nbsp;

Management

Clorox CFO Kevin Jacobsen Decides To Retire Effective April 1; Luc Bellet Named To Succeed

CloroxPro Announced The Expansion Of The Ecoclean Product Portfolio With The Launch Of CloroxPro Clorox Ecoclean Disinfecting Wipes

Barclays analyst Lauren Lieberman maintains Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) with a Underweight and lowers the price target from $139 to $130.

Barclays Maintains Underweight on Clorox, Lowers Price Target to $130

JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) with a Neutral and raises the price target from $167 to $171.

JP Morgan Maintains Neutral on Clorox, Raises Price Target to $171

In the current market session, Clorox Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) share price is at $158.44, after a 0.62% spike. Moreover, over the past month, the stock fell by 2.93%, but in the past year, went up by 9.97%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1736885713_0.png" alt="Past Year Chart" />

<h3>Evaluating Clorox P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Clorox has a better P/E ratio of 54.68 than the aggregate P/E ratio of 29.17 of the Household Products industry. Ideally, one might believe that Clorox Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1736885713_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

P/E Ratio Insights for Clorox

Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $155.29, a high estimate of $174.00, and a low estimate of $137.00. Observing a 6.78% increase, the current average has risen from the previous average price target of $145.43. 
<img src="https://www.benzinga.com/files/images/story/2025/1736258409_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of Clorox by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$157.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Robert Moskow</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$170.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$171.00</td>
<td>$153.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$139.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Javier Escalante</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$139.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$137.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$174.00</td>
<td>$148.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Clorox. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Clorox compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Clorox's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Clorox's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CLX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Clorox analyst ratings.</a>
<h2>Get to Know Clorox Better</h2>
Since its inception more than 100 years ago, Clorox has grown to play in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just less than 85% of Clorox's sales stem from its home turf.
<h3>Financial Insights: Clorox</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Clorox's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 27.13%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Net Margin: Clorox's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 5.62%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Clorox's ROE excels beyond industry benchmarks, reaching 51.03%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Clorox's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.76%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Clorox's debt-to-equity ratio stands notably higher than the industry average, reaching 48.07. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

7 Analysts Have This To Say About Clorox

Wells Fargo analyst Chris Carey upgrades Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) from Underweight to Equal-Weight and raises the price target from $155 to $157.

Upgrades

Wells Fargo Upgrades Clorox to Equal-Weight, Raises Price Target to $157

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/580f253b846faa000139ba71/robert-moskow">TD Cowen analyst Robert Moskow</a> upgraded the rating for The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) from Sell to Hold and raises the price target from $155 to $170. Clorox shares closed at $162.42 on Tuesday. <a href="https://www.benzinga.com/quote/CLX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Trevor Young upgraded Revolve Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) from Underweight to Equal-Weight and raised the price target from $17 to $25. Revolve shares closed at $26.02 on Tuesday. <a href="https://www.benzinga.com/quote/RVLV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/616e99feb650db000151570b/rick-bienkowski">Leerink Partners analyst Rick Bienkowski</a> upgraded the rating for Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) from Market Perform to Outperform and increased the price target from $27 to $39. Beam Therapeutics shares closed at $23.93 on Tuesday. <a href="https://www.benzinga.com/quote/BEAM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank analyst David Begleiter upgraded Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Hold to Buy and lowered the price target from $135 to $110. Celanese shares closed at $91.00 on Tuesday. <a href="https://www.benzinga.com/quote/CE/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>

Considering buying CLX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="547" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06082758/image-49-1024x547.png" alt="" class="wp-image-632747" style="width:636px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06082758/image-49-1024x547.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06082758/image-49-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06082758/image-49-768x410.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06082758/image-49.png 1230w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>

BEAM

RVLV

This Clorox Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday

TD Cowen analyst Robert Moskow upgrades Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) from Sell to Hold and raises the price target from $155 to $170.

TD Cowen Upgrades Clorox to Hold, Raises Price Target to $170

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>B. Riley Securities slashed The Estée Lauder Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) price target from $95 to $70. B. Riley Securities analyst Anna Glaessgen maintained a Neutral rating. Estée Lauder shares closed at $66.58 on Friday. <a href="https://www.benzinga.com/quote/EL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley raised the price target for Mastercard Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) from $540 to $544. Morgan Stanley analyst James Faucette maintained an Overweight rating. Mastercard shares closed at $508.08 on Friday. <a href="https://www.benzinga.com/quote/MA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank cut the price target for Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) from $69 to $46. Deutsche Bank analyst Lee Horowitz maintained a Buy rating. Wayfair shares closed at $40.15 on Friday. <a href="https://www.benzinga.com/quote/W/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital increased Reinsurance Group of America, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) price target from $235 to $245. RBC Capital analyst Scott Heleniak maintained an Outperform rating. Reinsurance Group shares settled at $215.10 on Friday. <a href="https://www.benzinga.com/quote/RGA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barrington Research slashed Insight Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSIT#NASDAQ">NSIT</a>) price target from $225 to $205. Barrington Research analyst Vincent Colicchio maintained an Outperform rating. Insight Enterprises shares closed at $172.21 on Friday. <a href="https://www.benzinga.com/quote/NSIT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>DA Davidson raised The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) price target from $153 to $171. DA Davidson analyst Linda Bolton Weiser maintained a Neutral rating. Clorox shares closed at $163.11 on Friday. <a href="https://www.benzinga.com/quote/CLX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Craig-Hallum increased the price target for CVRx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) from $15 to $20. Craig-Hallum analyst Alexander Nowak maintained a Buy rating. CVRx shares settled at $13.40 on Friday. <a href="https://www.benzinga.com/quote/CVRX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wedbush cut Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) price target from $62 to $32. Wedbush analyst Matt Bryson maintained a Neutral rating. Super Micro Computer shares closed at $26.05 on Friday. <a href="https://www.benzinga.com/quote/SMCI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Roth MKM lowered the price target for Energy Fuels Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUUU#NYSE">UUUU</a>) from $6 to $5.5. Roth MKM analyst Joe Reagor maintained a Neutral rating. Energy Fuels shares closed at $5.60 on Friday. <a href="https://www.benzinga.com/quote/UUUU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS boosted Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) price target from $170 to $200. UBS analyst Timothy Arcuri maintained a Buy rating. Broadcom shares closed at $168.92 on Friday. <a href="https://www.benzinga.com/quote/AVGO/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41713185/top-4-tech-and-telecom-stocks-that-may-collapse-this-month">Top 4 Tech And Telecom Stocks That May Collapse This Month</a></li>
</ul>

AVGO

CVRX

NSIT

UUUU

Broadcom To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday

DA Davidson analyst Linda Bolton Weiser maintains Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) with a Neutral and raises the price target from $153 to $171.

DA Davidson Maintains Neutral on Clorox, Raises Price Target to $171

Across the recent three months, 9 analysts have shared their insights on Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $154.89, a high estimate of $187.00, and a low estimate of $130.00. This upward trend is apparent, with the current average reflecting a 6.09% increase from the previous average price target of $146.00.
<img src="https://www.benzinga.com/files/images/story/2024/1730487623_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Clorox among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$139.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Javier Escalante</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$139.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$137.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$174.00</td>
<td>$148.00</td>
</tr>
<tr>
<td>Kaumil Gajrawala</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$187.00</td>
<td>$174.00</td>
</tr>
<tr>
<td>Wendy Nicholson</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$170.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$153.00</td>
<td>$153.00</td>
</tr>
<tr>
<td>Wendy Nicholson</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$165.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$130.00</td>
<td>$122.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Clorox. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Clorox compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Clorox's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Clorox's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CLX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Clorox analyst ratings.</a>
<h2>Delving into Clorox's Background</h2>
Since its inception more than 100 years ago, Clorox has grown to play in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just less than 85% of Clorox's sales stem from its home turf.
<h3>A Deep Dive into Clorox's Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Clorox's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 27.13% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Staples sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 5.62%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Clorox's ROE excels beyond industry benchmarks, reaching 51.03%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Clorox's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.76%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Clorox's debt-to-equity ratio surpasses industry norms, standing at 48.07. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Clorox Through The Eyes Of 9 Analysts

Barclays analyst Lauren Lieberman maintains Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) with a Underweight and raises the price target from $137 to $139.

Barclays Maintains Underweight on Clorox, Raises Price Target to $139

Clorox ( ($CLX) ) has provided an announcement. The Clorox Company announced that Kevin Jacobsen, their Chief Financial Officer, will retire on Apr...

Clorox Announces CFO Transition for Future Growth

Clorox Is Overpriced Versus Other Consumer Staples Stocks (Rating Downgrade)

Steven Cress' Top 10 Dividend Stocks For 2025

Catalyst Watch: Tariff drama, OPEC+, Alphabet and Amazon earnings, Lennar spinoff

Busy Earnings Season Continues With Alphabet, Disney, Palantir To Report Results

Wall Street Week Ahead

Earnings week ahead: PLTR, AMZN, GOOG, AMD, LLY, PEP, F, PFE, MRK, PYPL and more

Clorox Q2 2025 Earnings Preview

Today, several major companies are expected to report earnings: Alliance Resource (ARLP), Capital Southwest (CSWC), Clorox (CLX), Idexx Laboratorie...

Options Volatility and Implied Earnings Moves Today, February 03, 2025

Here are the major earnings after the close today

ACCD

AFRM

AMGN

ARCC

ATER

ATSG

BBAI

BYND

CBOE

CCIR

CELH

CTRE

DXPE

ENPH

EXPE

FCEL

GMVHF

GPRO

HBAN

HIMX

ICAD

ITRN

JBHT

LUCK

LVWR

MARK

MCHP

MDLZ

MTCH

NBIX

NLCP

NVDA

ONVO

OSCR

PEPG

PINS

PMNT

PTON

PYPL

QCOM

QUBT

RBLX

REGN

REKR

SASR

SDST

SILV

SNAP

SPOT

TSX:RCT

TTAM

TTWO

UBER

VICI

WLYB

XPEV

Entertainment

Press Releases

JASON KELCE ANNOUNCES KINGSFORD'S SEARCH FOR "KING OF THE TAILGATE"

Commodities

Clorox Announces Partnership with M2030 to Advance Supply Chain Climate Action

Dividends

Clorox Declares Regular Quarterly Dividend of $1.22 Per Share

Clorox Announces Election of Stephen Bratspies and Pierre Breber to its Board of Directors

Clorox EcoClean Disinfecting Wipes Win 2024 ISSA Environment & Sustainability Innovation of the Year Award

/C O R R E C T I O N -- CloroxPro/

Clorox Announces Feb. 3 Webcast of Second-Quarter Fiscal Year 2025 Results

CloroxPro's Latest Clean Index Report Reveals Increased Call for Eco-Conscious Solutions

CloroxPro™ Canada introduces new plant-based Clorox™ EcoClean Disinfecting Wipes for professional settings as eco-conscious product adoption reaches all-time high

Comments

Clorox

Clorox (CLX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL